Chembio Stock Buy Hold or Sell Recommendation

CEMI
 Stock
  

USD 0.67  0.02  3.08%   

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Chembio Diagnostics is 'Hold'. Macroaxis provides Chembio Diagnostics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CEMI positions. The advice algorithm takes into account all of Chembio Diagnostics' available fundamental, technical, and predictive indicators you will find on this site.
  
Refresh
The advice is provided from Chembio Diagnostics' buy-and-hold perspective. Continue to Chembio Diagnostics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Chembio and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Chembio Diagnostics.

Execute Chembio Diagnostics Buy or Sell Advice

The Chembio recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Chembio Diagnostics. Macroaxis does not own or have any residual interests in Chembio Diagnostics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Chembio Diagnostics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Chembio DiagnosticsBuy Chembio Diagnostics
Sell

Volatility

Out of controlDetails

Hype Condition

Over hypedDetails

Current Valuation

OvervaluedDetails

Odds of Distress

Very HighDetails

Economic Sensitivity

Follows the market closelyDetails

Analyst Consensus

HoldDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Chembio Diagnostics has a Mean Deviation of 4.12, Standard Deviation of 6.06 and Variance of 36.68
We provide trade advice to complement the prevailing expert consensus on Chembio Diagnostics. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Chembio Diagnostics is not overpriced, please confirm all Chembio Diagnostics fundamentals, including its gross profit, book value per share, and the relationship between the price to earning and cash per share . As Chembio Diagnostics appears to be a penny stock we also recommend to validate its number of shares shorted numbers.

Chembio Diagnostics Trading Alerts and Improvement Suggestions

Chembio Diagnostics generated a negative expected return over the last 90 days
Chembio Diagnostics has high historical volatility and very poor performance
Chembio Diagnostics has some characteristics of a very speculative penny stock
Chembio Diagnostics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 47.82 M. Net Loss for the year was (33.9 M) with profit before overhead, payroll, taxes, and interest of 12.83 M.
Chembio Diagnostics currently holds about 28.77 M in cash with (30.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from www.benzinga.com: Global HIV Diagnostics Test Market to Surpass US 8,487.17 Million by 2030 - Coherent Market Insights - B - Benzinga

Chembio Diagnostics current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Chembio analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Chembio analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Recommendation Mean3.00
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Chembio Diagnostics Returns Distribution Density

The distribution of Chembio Diagnostics' historical returns is an attempt to chart the future uncertainty of Chembio Diagnostics' future price movements. The chart of the probability distribution of Chembio Diagnostics stock daily returns describes the distribution of returns around its average expected value. We use Chembio Diagnostics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Chembio Diagnostics returns is essential to provide solid investment advice for Chembio Diagnostics stock.
Mean Return-0.27Value At Risk-8.45
Potential Upside11.94Standard Deviation6.06
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Chembio Diagnostics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Chembio Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Chembio Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chembio Diagnostics backward and forwards among themselves. Chembio Diagnostics' institutional investor refers to the entity that pools money to purchase Chembio Diagnostics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Vanguard Group IncCommon Shares1.1 M906 K
Blackrock IncCommon Shares282.5 K231 K
Geode Capital Management LlcCommon Shares274.4 K225 K
Susquehanna Fundamental Investments LlcCommon Shares206.4 K169 K
Royce Associates LpCommon Shares135.8 K111 K
Bank Of New York Mellon CorpCommon Shares124.8 K102 K
Engineers Gate Manager LpCommon Shares113.4 K93 K
Susquehanna International Group LlpPut Options86.1 K71 K
Group One Trading LpCall Options25.5 K21 K
Note, although Chembio Diagnostics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Chembio Diagnostics Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(1.03 M)(1.47 M)(3.5 M)(3.96 M)(1.82 M)(1.97 M)
Depreciation Amortization and Accretion1.28 M902.5 K1.92 M2.7 M2.93 M3.16 M
Net Cash Flow or Change in Cash and Cash Equivalents(6.76 M)8.73 M5.75 M4.79 M5.71 M6.16 M
Issuance Purchase of Equity Shares34.8 K27.55 M32.49 K28.44 M38.9 M41.97 M
Net Cash Flow from Financing134.28 K27.48 M18.49 M27.76 M38.69 M41.74 M
Net Cash Flow from Investing(1.88 M)(6.96 M)(3.75 M)(4.17 M)(1.86 M)(2 M)
Net Cash Flow from Operations(5.03 M)(11.78 M)(9.06 M)(18.89 M)(30.89 M)(31.7 M)
Share Based Compensation384.9 K632.8 K1.66 M1.22 M2.43 M2.62 M

Chembio Diagnostics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Chembio Diagnostics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Chembio Diagnostics stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Chembio stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-0.17
β
Beta against DOW0.71
σ
Overall volatility
6.18
Ir
Information ratio -0.02

Chembio Diagnostics Volatility Alert

Chembio Diagnostics is displaying above-average volatility over the selected time horizon. Investors should scrutinize Chembio Diagnostics independently to ensure intended market timing strategies are aligned with expectations about Chembio Diagnostics volatility. Chembio Diagnostics is a potential penny stock. Although Chembio Diagnostics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Chembio Diagnostics. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Chembio instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Chembio Diagnostics Fundamentals Vs Peers

Comparing Chembio Diagnostics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Chembio Diagnostics' direct or indirect competition across all of the common fundamentals between Chembio Diagnostics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Chembio Diagnostics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Chembio Diagnostics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Chembio Diagnostics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Chembio Diagnostics to competition
FundamentalsChembio DiagnosticsPeer Average
Return On Equity(109.29) %(0.31) %
Return On Asset(21.72) %(0.14) %
Profit Margin(70.90) %(1.27) %
Operating Margin(50.20) %(5.51) %
Current Valuation14.39 M16.62 B
Shares Outstanding30.05 M571.82 M
Shares Owned by Insiders1.31 %10.09 %
Shares Owned by Institutions11.71 %39.21 %
Number of Shares Shorted1.77 M4.71 M
Price to Earning(8.49) X28.72 X
Price to Book0.42 X9.51 X
Price to Sales0.42 X11.42 X
Revenue47.82 M9.43 B
Gross Profit12.83 M27.38 B
EBITDA(21.07 M)3.9 B
Net Income(33.9 M)570.98 M
Cash and Equivalents28.77 M2.7 B
Cash per Share0.96 X5.01 X
Total Debt25.86 M5.32 B
Debt to Equity0.75 %48.70 %
Current Ratio3.59 X2.16 X
Book Value Per Share1.60 X1.93 K
Cash Flow from Operations(30.89 M)971.22 M
Short Ratio8.21 X4.00 X
Earnings Per Share(1.24) X3.12 X
Price to Earnings To Growth(0.02) X4.89 X
Number of Employees33718.84 K
Beta1.64-0.15
Market Capitalization20.29 M19.03 B
Total Asset20.82 M29.47 B
Retained Earnings(73.47 M)9.33 B
Working Capital9.48 M1.48 B
Current Asset12.63 M9.34 B
   Acquisition by Tesolichtman Leslie of 41143 shares of Chembio Diagnostics subject to Rule 16b-3 [view details]

Chembio Diagnostics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Chembio . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution1680.88
Daily Balance Of Power0.6667
Rate Of Daily Change1.03
Day Median Price0.67
Day Typical Price0.67
Market Facilitation Index0.0
Price Action Indicator0.015

About Chembio Diagnostics Buy or Sell Advice

When is the right time to buy or sell Chembio Diagnostics? Buying financial instruments such as Chembio Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Chembio Diagnostics investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2020 2021 2022 (projected)
Receivables3.66 M3.38 M11.44 M12.34 M
Inventories9.6 M12.52 M12.92 M13.94 M

Use Investing Ideas to Build Portfolios

In addition to having Chembio Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Silver Thematic Idea Now

Silver
Silver Theme
Companies involved in mining, production, and distribution of silver and silver goods. The Silver theme has 30 constituents.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Silver Theme or any other thematic opportunities.
View All  Next Launch Silver
Continue to Chembio Diagnostics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Is Chembio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chembio Diagnostics. If investors know Chembio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chembio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
19.6 M
Quarterly Revenue Growth YOY
1.16
Return On Assets
-0.26
Return On Equity
-1.53
The market value of Chembio Diagnostics is measured differently than its book value, which is the value of Chembio that is recorded on the company's balance sheet. Investors also form their own opinion of Chembio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Chembio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chembio Diagnostics' market value can be influenced by many factors that don't directly affect Chembio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chembio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Chembio Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chembio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.